Introduction: Idiopathic pulmonary fibrosis (IPF) is a progressive and invariable fatal
interstitial lung disease. Current antifibrotic treatment halts disease progression but does not …

Snoring, obesity, older age, and male gender are well known risk factors for OSA. Men have
a two-fold greater risk of OSA than premenopausal women but men and women are affected …

Idiopathic pulmonary fibrosis, the most common of the idiopathic interstitial pneumonias, is
an irreversible, unpredictable, and ultimately fatal disorder of unknown cause. 1 The …

Background Pulmonary hypertension (PH) is common in patients with idiopathic pulmonary
fibrosis (IPF) and is associated with poor outcomes. This study was performed to determine …

Idiopathic pulmonary fibrosis (IPF), the most common and lethal of all chronic idiopathic
interstitial pneumonias, is a disease that is rare and is still regarded as an orphan condition …

The “treatment era” for idiopathic pulmonary fibrosis (IPF) in the United States and other
countries was inaugurated in November 2014 following the Food and Drug Administration's …

Background Identifying systemic sclerosis (SSc) and idiopathic pulmonary fibrosis (IPF)
patients at risk of more rapid forced vital capacity (FVC) decline could improve trial design …

Pulmonary fibrosis is a chronic and generally fatal disorder characterized by progressive
formation of scar-like tissue in the lungs. Sialic acids are often found as the terminal sugar …

Idiopathic pulmonary fibrosis (IPF) is a chronic, progressive disorder associated with a poor
prognosis. Until recently, there has been limited evidence that any drug could alter the …

Crohn's disease (CD) is characterized by the frequent occurrence of complications, such as
fibrotic strictures and subsequently the need for CD-related surgery. Chronic or recurrent …